Holen Sie sich die Stockscreener-App
4.36
3.53%
-0.15
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.51
Offen:
$4.52
24-Stunden-Volumen:
2.12M
Relative Volume:
0.27
Marktkapitalisierung:
$743.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.34M
KGV:
-3.2059
EPS:
-1.36
Netto-Cashflow:
$-36.91M
1W Leistung:
+9.32%
1M Leistung:
+57.07%
6M Leistung:
+136.46%
1J Leistung:
+339.96%
1-Tages-Spanne:
$4.32
$4.53
1-Wochen-Bereich:
$3.80
$4.84
52-Wochen-Spanne:
$0.9516
$5.1765
Sellas Life Sciences Group Inc Stock (SLS) Company Profile
Firmenname
Sellas Life Sciences Group Inc
Sektor
Branche
Telefon
(646) 200-5278
Adresse
7 TIMES SQUARE, NEW YORK, NY
Vergleichen Sie SLS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLS
Sellas Life Sciences Group Inc
|
4.365 | 767.97M | 0 | -37.34M | -36.91M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.63 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.34 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
811.57 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.84 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Sellas Life Sciences Group Inc Stock (SLS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-11-01 | Eingeleitet | Oppenheimer | Outperform |
| 2018-04-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Hochstufung | Maxim Group | Hold → Buy |
Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten
Heightened Volatility Marks Sellas Life Sciences as Key Clinical Milestones Approach - AD HOC NEWS
Best Penny Stocks To Follow TodayJanuary 4th - MarketBeat
Sellas Life Sciences Rises as Traders Weigh REGAL Debate and Microcap Volatility - StocksToTrade
Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS) - Seeking Alpha
Will SELLAS Life Sciences Group Inc. stock see PE expansion2025 Pullback Review & Proven Capital Preservation Methods - bollywoodhelpline.com
Sellas Life Sciences Shares Surge with Strategic Clinical Study Moves - StocksToTrade
SELLAS Life Sciences’ European Partnership Spurs Market Optimism - timothysykes.com
Key Developments in SLS’s Market Strategy - StocksToTrade
SELLAS Life Sciences Rallies After Major Trial Developments - timothysykes.com
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration - simplywall.st
Sellas Life Sciences Stock Dips as Volatility Returns After Recent Headlines - StocksToTrade
Sellas Life Sciences Expands SLS009 Program Into Europe With IMPACT-AML Agreement - StocksToTrade
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 5.5%Should You Sell? - MarketBeat
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe - Sahm
SELLAS partners with IMPACT-AML for European SLS009 trials By Investing.com - Investing.com Nigeria
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement - Yahoo Finance
How SELLAS’s IMPACT-AML Trial Expansion At SELLAS Life Sciences Group (SLS) Has Changed Its Investment Story - simplywall.st
SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout - Asianet Newsable
SELLAS partners with IMPACT-AML for European SLS009 trials - Investing.com
Aug Fed Impact: Is CACC trading at a discountVolume Spike & Fast Moving Stock Trade Plans - baoquankhu1.vn
SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 REGAL Trial Progress - Quiver Quantitative
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Up 10.3%Here's What Happened - MarketBeat
Sellas Life Sciences Jumps in Volatile Session After Recent Selloff - StocksToTrade
Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat
Sellas Life Sciences Rebounds After Volatile Selloff - timothysykes.com
Sellas Life Sciences Stock Slides as Trading Dynamics Overshadow Trial Timeline Update - StocksToTrade
Published on: 2026-01-10 22:25:31 - Улправда
SELLAS Stock Dips Amid Volatility After Warrant Exercise Update - StocksToTrade
Sellas Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? - Asianet Newsable
SLS Stock Slides Amid Volatility as Traders Focus on Dilution Concerns - timothysykes.com
SELLAS Life Sciences Falls For Fourth Straight SessionWhat's Driving The Sell Off? - Menafn
Published on: 2026-01-08 22:04:52 - Улправда
Is SELLAS Life Sciences Group Inc. stock a top pick in earnings seasonJuly 2025 Catalysts & Expert-Curated Trade Recommendations - Улправда
Published on: 2026-01-09 05:48:17 - Улправда
Why SELLAS Life Sciences Group Inc. stock could outperform in 2025July 2025 Breakouts & AI Powered Buy/Sell Recommendations - Улправда
Investment Review: Why global investors buy SELLAS Life Sciences Group Inc. (RXK3) stock2025 Valuation Update & Scalable Portfolio Growth Ideas - ulpravda.ru
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech - GlobeNewswire
SELLAS Life Sciences Group stock soars as it nears final analysis in cancer study - MSN
Dip Buying: How interest rate cuts could boost SELLAS Life Sciences Group Inc. stockJuly 2025 Earnings & AI Optimized Trading Strategy Guides - ulpravda.ru
SELLAS Raises $26.5 Million Through Warrant Exercises - TipRanks
SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B - Asianet Newsable
Penny Stocks To Follow TodayJanuary 3rd - MarketBeat
SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 8.4%Here's Why - MarketBeat
Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):